作者: Sonia M. Grandi , Kristian B. Filion , André Gervais , Lawrence Joseph , Jennifer O'Loughlin
DOI: 10.1016/J.AMJMED.2014.02.032
关键词:
摘要: Abstract Background Current guidelines recommend smoking cessation and weight management for secondary prevention in patients post-myocardial infarction. However, little is known about the effects of on change Methods We examined patterns its blood pressure glycemic control using data from a randomized trial investigating effect bupropion Weight was compared among 3 groups patients: those who were completely abstinent (n = 92), smoked intermittently 49), persistently 38) during 12-month follow-up. Analyses restricted to attended all follow-up visits. Results The median at baseline 77.1 kg (interquartile range [IQR], 66.0, 87.5), 64.3% overweight/obese (body mass index ≥25.0 kg/m 2 ). gain 12 months 4.0 (IQR, 0-7.0), with more than one third gaining >5 kg. proportion increased by approximately 10%, 23.2% moved up body category. Abstainers gained 4.8 1.0, 8.6), intermittent smokers 2.0 (IQR, −2.0, 5.0), persistent 3.0 (IQR, −0.8, 6.0). associated an increase requirements hypoglycemic medications months. Conclusions majority attempting quit infarction, abstainers return smoking. prevalence hypertension diabetes.